Ignite Creation Date:
2025-12-24 @ 11:05 PM
Ignite Modification Date:
2025-12-30 @ 3:56 PM
Study NCT ID:
NCT03231969
Status:
COMPLETED
Last Update Posted:
2023-03-16
First Post:
2017-07-20
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Single-Center, Phase 2 Study Evaluating Bilastine Ophthalmic Solution in the CAC® Model
Sponsor:
Faes Farma, S.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
BOFT-0117/DR-CAC
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |